These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of chromogranin A and pancreastatin levels in plasma of patients with pancreatic islet cell tumor. Tateishi K; Kitayama N; Matsuoka Y; Funakoshi A Life Sci; 1995; 57(9):889-95. PubMed ID: 7630318 [TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of a tumor-derived human protein related to chromogranin A and its in vitro conversion to human pancreastatin-48. Tamamura H; Ohta M; Yoshizawa K; Ono Y; Funakoshi A; Miyasaka K; Tateishi K; Jimi A; Yajima H; Fujii N Eur J Biochem; 1990 Jul; 191(1):33-9. PubMed ID: 2165909 [TBL] [Abstract][Full Text] [Related]
11. The occurrence of pancreastatin in tumours of the diffuse neuroendocrine system. Bishop AE; Bretherton-Watt D; Hamid QA; Fahey M; Shepherd N; Valentino K; Tatemoto K; Ghatei MA; Bloom SR; Polak JM Mol Cell Probes; 1988 Sep; 2(3):225-35. PubMed ID: 2851738 [TBL] [Abstract][Full Text] [Related]
12. Chromogranin A and pancreastatin-like immunoreactivity in normal pregnancies. Syversen U; Opsjøn SL; Stridsberg M; Sandvik AK; Dimaline R; Tingulstad S; Arntzen KJ; Brenna E; Waldum HL J Clin Endocrinol Metab; 1996 Dec; 81(12):4470-5. PubMed ID: 8954061 [TBL] [Abstract][Full Text] [Related]
13. Unique change of pancreastatin-like immunoreactivity in cerebrospinal fluid by aging. Sekiya K; Nakao R; Takayanagi R; Haji M; Kurose S; Oyama M; Ohashi M; Tateishi K; Funakoshi A; Akazawa K Neurosci Lett; 1994 Mar; 170(1):179-82. PubMed ID: 8041502 [TBL] [Abstract][Full Text] [Related]
14. Secretion of chromogranin A by peptide-producing endocrine neoplasms. O'Connor DT; Deftos LJ N Engl J Med; 1986 May; 314(18):1145-51. PubMed ID: 3007986 [TBL] [Abstract][Full Text] [Related]
15. Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM). Funakoshi A; Tateishi K; Shinozaki H; Matsumoto M; Wakasugi H Regul Pept; 1990 Sep; 30(2):159-64. PubMed ID: 2274680 [TBL] [Abstract][Full Text] [Related]
16. Pancreastatin distribution and plasma levels in the pig. Bretherton-Watt D; Ghatei MA; Bishop AE; Facer P; Fahey M; Hedges M; Williams G; Valentino KL; Tatemoto K; Roth K Peptides; 1988; 9(5):1005-14. PubMed ID: 3244555 [TBL] [Abstract][Full Text] [Related]
17. Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension. Sánchez-Margalet V; Valle M; Lobón JA; Escobar-Jiménez F; Pérez-Cano R; Goberna R Neuropeptides; 1995 Aug; 29(2):97-101. PubMed ID: 7477767 [TBL] [Abstract][Full Text] [Related]
18. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome. Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426 [TBL] [Abstract][Full Text] [Related]
19. Acetylcholine regulates pancreastatin secretion from the human pancreastatin-producing cell line (QGP-1N). Funakoshi A; Tateishi K; Tsuru M; Jimi A; Wakasugi H; Kono A J Clin Endocrinol Metab; 1991 Jul; 73(1):151-5. PubMed ID: 1646215 [TBL] [Abstract][Full Text] [Related]
20. Isolation of human pancreastatin fragment containing the active sequence from a glucagonoma. Sekiya K; Ghatei MA; Minamino N; Bretherton-Watt D; Matsuo H; Bloom SR FEBS Lett; 1988 Feb; 228(1):153-6. PubMed ID: 2830133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]